scholarly journals Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer

2004 ◽  
Vol 96 (10) ◽  
pp. 759-769 ◽  
Author(s):  
M. D. Pegram ◽  
T. Pienkowski ◽  
D. W. Northfelt ◽  
W. Eiermann ◽  
R. Patel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Advanced Breast ◽  
Her2 Positive ◽  
Open Label ◽  
Multicenter Phase ◽  
Platinum Salts ◽  
Phase Ii Studies

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (7) ◽  
pp. 689-699 ◽  
Author(s):  
Ian E Krop ◽  
Sung-Bae Kim ◽  
Antonio González-Martín ◽  
Patricia M LoRusso ◽  
Jean-Marc Ferrero ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Versus Treatment

Suramin in Non-small Cell Lung Cancer and Advanced Breast Cancer: Two Parallel Phase II Studies

1997 ◽  
Vol 36 (2) ◽  
pp. 171-174 ◽  
Author(s):  
Mansoor R. Mirza ◽  
Erik Jakobsen ◽  
Per Pfeiffer ◽  
Bente Lindebjerg-Clasen ◽  
Jonas Bergh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Breast ◽  
Small Cell Lung ◽  
Phase Ii Studies
Sign in / Sign up

Export Citation Format

Share Document